Correction: Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review

J Endocrinol Invest. 2024 May;47(5):1313. doi: 10.1007/s40618-023-02247-5.

Authors

Diana Zúñiga¹, M A M Stumpf², A L S Monteiro¹, A Glezer¹

Affiliations

¹ Neuroendocrine Unit, Division of Endocrinology and Metabolism, University of São Paulo Medical School Hospital, R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo, SP, 05403-010, Brazil.
² Neuroendocrine Unit, Division of Endocrinology and Metabolism, University of São Paulo Medical School Hospital, R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo, SP, 05403-010, Brazil. matheo.augusto@hc.fm.usp.br.

PMID: 38079105
DOI: 10.1007/s40618-023-02247-5

No abstract available

Publication types

Published Erratum